Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0002736 (
amyotrophic lateral sclerosis
)
19,048
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
In an autopsy case of sporadic
amyotrophic lateral sclerosis
, there were intracytoplasmic eosinophilic inclusions of the Bunina type in motor neurons. Electron microscopically, these bodies were observed as amorphous substances, irregularly deposited around the endoplasmic reticulum to form masses. Similar small masses were also visible in mitochondria. These substances did not stain for
acid phosphatase
. By analytical electron microscopy they contained silicon. Bunina bodies, therefore, seem to be due to deposition of some metabolite, but their nature is still obscure.
...
PMID:Intracytoplasmic inclusions (Bunina bodies) in amyotrophic lateral sclerosis. 625 94
A selection of 43 Candida albicans isolates, chosen to represent the four major strain clades of the species and also intraclade diversity, was screened for their virulence in the murine intravenous challenge model of C. albicans infection, for a range of properties measurable in vitro that might relate to virulence, and for the numbers of midrepeat sequences in genes of the
ALS
and HYR families. Heterozygosity at the mating type locus and low whole-cell
acid phosphatase
activity and growth rate at 40 degrees C were found to be significantly positively associated with the most virulent isolates. Acid phosphatase activity and growth in 2 M NaCl were statistically significant variables between clades by univariate analysis. Isolates in different clades also differed significantly in midrepeat sequence alleles of ALS2, ALS4, ALS6, ALS7, ALS9, HYR1, and HYR2. There was no association between the midrepeat alleles of any
ALS
or HYR gene and the virulence of isolates to mice. Genome-wide transcript profiles of 20 isolates (5 per clade) grown under two conditions showed considerable variation between individual isolates, but only a small number of genes showed statistically significant differential gene expression between clades. Analysis of the expression profiles by overall strain virulence revealed 18 open reading frames differing significantly between isolates of high, intermediate, and low virulence. Four of these genes encoded functions related to phosphate uptake and metabolism. This finding and the significant association between whole-cell
acid phosphatase
activity and virulence led us to disrupt PHO100, which encodes a predicted periplasmic
acid phosphatase
. The pho100Delta mutant was mildly but significantly attenuated in terms of survival curves in the mouse model. The study has extended the range of properties known to differ between C. albicans clades and suggests a possible but minor role of phosphate metabolism in the virulence of the species.
...
PMID:Property differences among the four major Candida albicans strain clades. 1915 28
An abnormally expanded GGGGCC repeat in C9ORF72 is the most frequent causal mutation associated with
amyotrophic lateral sclerosis
(
ALS
)/frontotemporal lobar degeneration (FTLD). Both
gain-of-function
(
gf
) and
loss-of-function
(
lf
) mechanisms have been involved in C9ORF72 related
ALS
/FTLD. The
gf
mechanism of C9ORF72 has been studied in various animal models but not in
C. elegans
. In the present study, we described mutant C9ORF72 modeling in
C. elegans
and report the finding of two suppressor genes. We made transgenes containing 9 or 29 repeats of GGGGCC in C9ORF72, driven by either the
hsp-16
promoters or the
unc-119
promoter. Transgenic worms were made to carry such transgenes. Phenotypic analysis of those animals revealed that
P
hsp
-
16
::(G4C2)
29
::GFP
transgenic animals (EAB 135) displayed severe paralysis by the second day of adulthood, followed by lethality, which phenotypes were less severe in
P
hsp
-
16
::(G4C2)
9
::GFP
transgenic animals (EAB242), and absent in control strains expressing empty vectors. Suppressor genes of this locomotor phenotype were pursued by introducing mutations with ethyl methanesulfonate in EAB135, screening mutant strains that moved faster than EAB135 by a food-ring assay, identifying mutations by whole-genome sequencing and testing the underlying mechanism of the suppressor genes either by employing RNA interference studies or
C. elegans
genetics. Three mutant strains, EAB164, EAB165 and EAB167, were identified. Eight suppressor genes carrying nonsense/canonical splicing site mutations were confirmed, among which a nonsense mutation of F57A10.2/VAMP was found in all three mutant strains, and a nonsense mutation of acp-4/ACP2 was only found in EAB164. Knock down/out of those two genes in EAB135 animals by feeding RNAi/introducing a known acp-4 null allele phenocopied the suppression of the C9ORF72 variant related movement defect in the mutant strains. Translational conformation in a mammalian system is required, but our worm data suggest that altering acp-4/ACP2 encoding lysosomal
acid phosphatase
may provide a potential therapeutic method of reducing acp-4/ACP2 levels, as opposed or complementary to directly reducing C9ORF72, to relieve C9ORF72-
ALS
phenotypes. It also suggests that the C9ORF72-
ALS
/FTLD may share a pathophysiologic mechanism with vesicle-associated membrane protein-associated protein B, a homolog of F57A10.2/VAMP, which is a proven ALS8 gene.
...
PMID:Forward Genetic Screen in
Caenorhabditis elegans
Suggests F57A10.2 and acp-4 As Suppressors of C9ORF72 Related Phenotypes. 2787 10